---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-22-016066"
form_type: "8-K"
ticker: "NDRA"
cik: "0001681682"
company_name: "ENDRA Life Sciences Inc."
filed_at: "2022-12-02T23:59:59+00:00"
generated_at: "2026-06-21T10:18:09.558657+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ENDRA Life Sciences shareholders approve reverse stock split; board sets 1-for-20 ratio

## Summary
- Shareholders approved amendment to authorize reverse stock split at ratio from 1-for-2 to 1-for-30.
- Board of Directors set the final ratio at 1-for-20 after the special meeting.
- Company intends to effect the reverse split before December 31, 2022.
- Vote results: 21,057,265,393 for, 7,433,237,535 against, 5,832,047,971 abstain.

## SEC filing metadata
- accession: 0001654954-22-016066
- form_type: 8-K
- ticker: NDRA
- cik: 0001681682
- company_name: ENDRA Life Sciences Inc.
- filed_at: 2022-12-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681682/000165495422016066/0001654954-22-016066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681682/000165495422016066/endra_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-22-016066
- JSON: https://secwatch.observer/filing/0001654954-22-016066.json
- Plain text: https://secwatch.observer/filing/0001654954-22-016066.txt

## Key facts
- Shareholder Votes
  ENDRA Life Sciences Inc. shareholders approved Amendment to Amended and Restated Certificate of Incorporation to effect a reverse stock split of common stock at a ratio between 1-for-2 and 1-for-30 at the 2022-11-29 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2022-11-29
  source text: The certified results of the matter voted upon at the meeting, which is more fully described in the definitive proxy statement filed with the Securities and Exchange Commission on October 17, 2022, are as follows: Proposal 1 – The stockholders of the Company approved an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) to effect, at the discretion of the Company’s Board of Directors (the “Board”) on or prior to the one-year anniversary of the date of the Special Meeting, a reverse stock split of the Company’s common stock at a stock split ratio between 1-for-2 and 1-for-30, with the ultimate ratio to be determined by the Board in its sole discretion, the implementation and timing of which shall be subject to the discretion of the Board, with votes cast as follows: For Against Abstain 21,057,265,393 7,433,237,535 5,832,047,971
  evidence_url: https://www.sec.gov/Archives/edgar/data/1681682/000165495422016066/0001654954-22-016066-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.